Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-05-17 @ 8:36 AM
Study NCT ID:
NCT06169202
Status:
RECRUITING
Last Update Posted:
2023-12-13
First Post:
2023-12-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients
Sponsor:
China Medical University, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FIRELIGHT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None